IL31 and granular corneal dystrophy type II: In 2006 [75] and 2018 studies [76] levels of IL-31 were found to be higher in skin samples of patients affected by ACD, suggesting a critical role in itch stimulation, but not in pathogenetic processes such as induction of inflammation and hapten-specific T-cell activation.